Symbols

XTNT

Xtant Medical·AMEX

--(--)

Signals Analysis

Bullish signal 6

Bearish signal 0

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

High Cash/net Profit Ratio

Revenue Beats Expectation

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About XTNT

Xtant Medical Holdings, Inc.

A global medical technology company focused on surgical solutions for the treatment of spinal disorders

Industry

Healthcare Equipment and Supplies

Established Date

Listing Date

10/19/2015

Exchange

American Stock Exchange

Full-time Employees

217

Fiscal Year Ends

12-31

Website

www.xtantmedical.com

Security Type

Common stock

Office address

664 Cruiser Lane , Belgrade , Montana 59714

Business

Introduction

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and sells vaccines to domestic and international markets for biological products. The vaccine's proprietary method for human-derived transplantation to the scaffold promotes bone and tissue growth. These products are used in a variety of applications, including enhancing fusion in spinal surgery, stabilizing facet joints to relieve back pain, promoting bone growth in foot and ankle surgery, neurosurgery in knee surgery after skull healing, and promoting regeneration.

Earnings Call

Q1/2025

Estimate EPS-0.01

Actual EPS0.28

Estimate Revenue31.22M

Actual Revenue32.90M

Xtant Medical's Q1 2025: Navigating Contradictions in Revenue Impact, Margin Expectations, and Market Growth

May 20,2025 05:01·
Earnings Decrypt

Q2/2025

Estimate EPS-0.02

Actual EPS0.02

Estimate Revenue31.35M

Actual Revenue30.44M

Xtant Medical's Q2 2025 Earnings Call: Unpacking Contradictions in Revenue, Strategy, and Growth Drivers

Aug 12,2025 10:52·
Earnings Decrypt

Company Financials

EPS

XTNT has released its 2025 Q3 earnings. EPS was reported at 0.01, versus the expected 0, beating expectations. The chart below visualizes how XTNT has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

XTNT has released its 2025 Q3 earnings report, with revenue of 33.26M, reflecting a YoY change of 19.04%, and net profit of 1.31M, showing a YoY change of 126.04%. The Sankey diagram below clearly presents XTNT's revenue sources and cost distribution.